Clinical Trial of AC105 (Mg/PEG) for Treatment of Acute Spinal Cord Injury (SCI). Phase 2

2013 ◽  
Author(s):  
Andrew Blight
Keyword(s):  
Clinical Trial ◽  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Acute Spinal Cord Injury ◽  
Phase 2 ◽  
Cord Injury

scholarly journals Outcome Measures for Acute/Subacute Cervical Sensorimotor Complete (AIS-A) Spinal Cord Injury During a Phase 2 Clinical Trial

2012 ◽  
Vol 18 (1) ◽  
pp. 1-14 ◽  
Author(s):  
John Steeves ◽  
Daniel Lammertse ◽  
John Kramer ◽  
Naomi Kleitman,* ◽  
Sukhvinder Kalsi-Ryan ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Outcome Measures ◽  
Phase 2 ◽  
Cord Injury ◽  
Phase 2 Clinical Trial

scholarly journals A Phase I/IIa Clinical Trial of a Recombinant Rho Protein Antagonist in Acute Spinal Cord Injury

2011 ◽  
Vol 28 (5) ◽  
pp. 787-796 ◽  
Author(s):  
Michael G. Fehlings ◽  
Nicholas Theodore ◽  
James Harrop ◽  
Gilles Maurais ◽  
Charles Kuntz ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Phase I ◽  
Acute Spinal Cord Injury ◽  
Cord Injury ◽  
Rho Protein

P166. The Cethrin Phase I/IIa Prospective Clinical Trial of a Cethrin for the Treatment of Acute Spinal Cord Injury

2007 ◽  
Vol 7 (5) ◽  
pp. 159S ◽  
Author(s):  
Michael Fehlings ◽  
Nicholas Theodore ◽  
James Harrop ◽  
Gilles Maurais ◽  
Charles Kuntz ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Phase I ◽  
Acute Spinal Cord Injury ◽  
Prospective Clinical Trial ◽  
Cord Injury
Sign in / Sign up

Export Citation Format

Share Document